Company intelligence / Profile preview

Colorado Chromatography Labs

Parker, Colorado, United Statescoloradochromatography.com ↗

Ownership: Private
Employees: ~30
Development stage: Commercial

Overview

Colorado Chromatography Labs specializes in the production of high-purity minor cannabinoids derived from hemp—including CBN (>99%), CBC, THCV, and CBDV—primarily for use as ingredients in pharmaceutical or wellness products. The company is recognized for its scientific approach to cannabinoid isolation and custom formulation services. While it conducts cannabis-based research and has contributed to preclinical studies on novel cannabinoids such as H4CBD[5], it does not have a clinical-stage therapeutic pipeline.

Modalities: Small molecule (cannabinoids and derivatives)
Industry: Chemicals & Materials

Drug pipeline

5 assets

CBN

Commercial

Indications: General wellness

4 more assets in the full pipeline.

Request access →

Beyond the preview

Go deeper on Colorado Chromatography Labs.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Colorado Chromatography Labs.

Explore the full profile